Carmichael Hill & Associates’s MetLife MET Stock Holding History

Carmichael Hill & Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$27K	Buy	327 +186	+132%	+$13.9K	0.01%	466
2024 Q2	$9.9K	Hold	141	–	–	﹤0.01%	568
2024 Q1	$10.4K	Sell	141 -164	-54%	-$11.4K	﹤0.01%	558
2023 Q4	$20.2K	Hold	305	–	–	0.01%	476
2023 Q3	$19.2K	Hold	305	–	–	0.01%	471
2023 Q2	$17.2K	Hold	305	–	–	0.01%	491
2023 Q1	$17.7K	Hold	305	–	–	0.01%	475
2022 Q4	$22.1K	Hold	305	–	–	0.01%	453
2022 Q3	$19K	Hold	305	–	–	0.01%	480
2022 Q2	$19K	Hold	305	–	–	0.01%	480
2022 Q1	$21K	Hold	305	–	–	0.01%	489
2021 Q4	$19K	Hold	305	–	–	0.01%	525
2021 Q3	$19K	Hold	305	–	–	0.01%	520
2021 Q2	$18K	Sell	305 -11	-3%	-$697	0.01%	526
2021 Q1	$19K	Hold	316	–	–	0.01%	504
2020 Q4	$15K	Hold	316	–	–	0.01%	513
2020 Q3	$12K	Buy	316 +225	+247%	+$8.54K	0.01%	503
2020 Q2	$3K	Hold	91	–	–	﹤0.01%	606
2020 Q1	$3K	Hold	91	–	–	﹤0.01%	580
2019 Q4	$5K	Buy	+91	New	+$4.39K	﹤0.01%	559

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Carmichael Hill & Associates's MET Position: Q3 2024 in Review

Carmichael Hill & Associates increased its MetLife (MET) stake by 132% in Q3 2024, buying an estimated $13.9K and bringing the position to 327 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #466.

Carmichael Hill & Associates first reported a position in MET in Q4 2019 and has held it in 20 quarters since. 1,315 funds tracked by Wall St. Rank hold MET as of Q3 2024.

Carmichael Hill & Associates held 327 shares of MetLife worth $27K as of Q3 2024.
Carmichael Hill & Associates bought 186 MetLife shares in Q3 2024, an estimated $13.9K.
MetLife made up 0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #466 holding.
Carmichael Hill & Associates first reported a position in MetLife in Q4 2019 and has held it in 20 quarters since.
1,315 funds tracked by Wall St. Rank held MetLife as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.